Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

HuR enhances SARS-CoV-2 non-structural protein translation through the genomic 5'-UTR, by promoting polypyrimidine tract-binding protein binding.

Journal of virology·2026

Same author

Fecal Calprotectin as a biomarker for early diagnosis and prediction of steroid response in Acute Gastrointestinal Graft versus Host Disease.

Blood cell therapy·2026

Same author

International Survey for Antiemetics in Hematopoietic Stem Cell Transplantation in the APBMT Centers.

Blood cell therapy·2026

Same author

Clinical Outcomes of Allogeneic Stem Cell Transplantation in Myelofibrosis - A Single Center Experience.

Blood cell therapy·2026

Same author

Efficacy of Standard-Dose Versus Low-Dose Nivolumab in Relapsed/Refractory Hodgkin Lymphoma-A Retrospective Analysis.

JCO global oncology·2026

Same author

Correction to: A meta-analysis of immunosuppressive and Pharmacological therapies in aplastic anaemia with and without Indigenous equine antithymocyte Globulin (eATG).

Annals of hematology·2026

Same journal

Do We Sin When Treating Patients with Higher-Risk Myelodysplastic Syndromes?

Transplantation and cellular therapy·2026

Same journal

Cytomegalovirus Interstitial Pneumonia: A Plague of Marrow Transplant That the Field Solved.

Transplantation and cellular therapy·2026

Same journal

Comparison of Carmustine-, Lomustine-, and Nitrosourea-free Conditioning Regimens for Autologous Hematopoietic Cell Transplantation in Lymphoma (auto-HTC): Results from the Hematopoietic Cell Transplantation Brazilian Registry (HCTBR).

Transplantation and cellular therapy·2026

Same journal

Reduced-dose post-transplant cyclophosphamide as graft-versus-host disease prophylaxis in matched donor allogeneic stem cell transplantation: a systematic review of efficacy and toxicity.

Transplantation and cellular therapy·2026

Same journal

Allogeneic Hematopoietic Cell Transplant Following Standard of Care Brexucabtagene Autoleucel (Brexu-cel) in Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL): Results from the Real-World Outcomes Collaborative of CAR T in Adult ALL (ROCCA).

Transplantation and cellular therapy·2026

Same journal

The association between hyponatremia and immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor T cell therapy.

Transplantation and cellular therapy·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jul 1, 2026

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

The Last Mile in CAR-T Cell Therapy

Biju George¹, Uday Kulkarni¹

¹Department of Haematology, CMC Vellore, India.

Transplantation and Cellular Therapy

|June 29, 2026

Summary

No abstract available in PubMed .

More Related Videos

Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Related Experiment Videos

Last Updated: Jul 1, 2026

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025